mRNA |
BRD-A94377914 |
CTRPv2 |
pan-cancer |
AAC |
0.068 |
0.1 |
mRNA |
tosedostat |
CTRPv2 |
pan-cancer |
AAC |
0.057 |
0.1 |
mRNA |
SB-225002 |
CTRPv2 |
pan-cancer |
AAC |
0.048 |
0.1 |
mRNA |
BRD-K27188169:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.08 |
0.1 |
mRNA |
XMD14-99 |
GDSC1000 |
pan-cancer |
AAC |
0.052 |
0.1 |
mRNA |
Rapamycin |
CTRPv2 |
pan-cancer |
AAC |
0.053 |
0.1 |
mRNA |
Compound 1541A |
CTRPv2 |
pan-cancer |
AAC |
0.06 |
0.1 |
mRNA |
MP470 |
GDSC1000 |
pan-cancer |
AAC |
0.053 |
0.1 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.057 |
0.1 |
mRNA |
TPCA-1 |
GDSC1000 |
pan-cancer |
AAC |
-0.044 |
0.1 |